Characteristics of patients with idiopathic intracranial hypertension treated with sinus angioplasty and stent placement (N=143)
| Studies | No of cases | Gender | Mean age | Mean BMI | CSF opening pressure (cm H2O) | Presenting symptoms | Mean pre-stent pressure gradient (mm Hg) | Mean post-stent pressure gradient (mm Hg) | Location of stent placement | Complications | Post-stent symptoms | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arac et al20 | 1 | F | 51 | 29 | 31 | HA, PT | 13 | 2 | RTS | None | Immediate resolution | 2 |
| Teleb et al30 | 1 | F | 22 | 28 | 48 | HA, VC, PAP | 26 | 0 | RTS | None | Resolution | 6 |
| Ogungbo et al21 | 1 | F | 37 | NR | >40 | HA, VC, PAP | 25 | NR | RTS | None | PAP reduction, symptom resolution | 6 |
| Paquet et al22 | 1 | F | 60 | NR | 30 | HA, VC, PAP | 15 | NR | RTS | None | Resolution | NR |
| Higgins et al29 | 1 | F | 30 | 30.1 | 35 | HA, VC, PAP | 18 | 3 | NR | None | Resolution | 12 |
| Zheng et al23 | 1 | F | 34 | 26.1 | 40 | HA, VC, PAP | 160 | 0 | LTS | None | Resolution | 3 |
| Rajpal et al24 | 1 | M | 15 | 26.9 | 37 | HA, VC, PAP | 25 | NR | RTS | None | Resolution | 6 |
| Kumpe et al1 | 18 | 12F, 6M | 37.9 (16–62) | 31.6 (22.6–38) | 39.6 (25–55) NR in 4 | HA-12, VC-17, PAP-16 | 21.4 (4–39) | 2.6 (0–7) | RTS-12, LTS-5, Bilat-1 | 1 Major (subdural), 2 minor (UTI, syncope) | HA resolved 10/12, unchanged in 2/12, PAP resolved 15/16, VC NR | 43.7 (11–136) |
| Ahmed et al28 | 52 | 47F, 5M | 34 (10–64) | >30 in 47 | 32.9 (25–73) NR in 11 | HA-43, VC-19, PAP-46, PT-17 | 19.1 (4–41) | 0.6 (0–14) | RTS-36, LTS-12, NR in 4 | 2 Major (subdural), 2 minor (transient hearing loss) | HA resolution 40/43, PAP resolution in 46 (4 with optic atrophy), VC resolution in 19, PT resolution in 17 | 24 (2–108) |
| Fields et al2 | 15 | 15F | 34 (20–56) | 39 (30–73) | NR | HA-15, PAP-15, VC-3, PT-14 | 24 (13–40) | 4 (0–9) | RTS-8, LTS-4, Bilat-3 | 1 Minor (femoral pseudoaneurysm) | HA resolution in 10/15, unchanged in 3, worse in 2, PAP resolution in 15/15, VC resolution in 2/3, PT resolution in 11/14 | 14 (1–49) |
| Albuquerque et al10 | 15 | 12F, 3M | 32.3 (15–51) | NR | NR | HA-15 | NR | NR | RTS-9, LTS-6 | 1 Minor (retroperitoneal hematoma) | HA resolution in 12/15, unchanged in 2, worse in 1 | 20 (2–40) |
| Owler et al25 | 4 | 3F, 1M | 27 (17–38) | 30 (23–38) | 29 (22–35) NR in 1 | HA-4, PAP-4, VC-4 | 19 (12–25) | .25 (0–1) | RTS-3, LTS-1 | None | Resolution | 9.8 (5–12) |
| Donnet et al26 | 10 | 8F, 2M | 41 (28–60) | 27.3 (22–37) | 40.2 (29–59) | HA-10, PAP-10, VC-10, PT-9 | 19.1 (12–34) | NR | RTS-7, LTS-2, Bilat-1 | None | HA resolution in 8/10, Unchanged in 2, PAP resolution 10/10, VC resolution in 9/10, PT resolution in 9/9 | 17.2 (6–36) |
| Bussiere et al27 | 10 | 10F | Median 34 (16–65)* | 35.9 (27–47 | NR | HA-10, PAP-9, VC-8 | 28.25 (11–50) | 11.25 (2–23) | NR | None | HA resolution in 10/10, PAP resolution in 9/9, VC resolution in 7/8 | 20.1 (4–60) |
| Higgins et al11 | 12 | 12F | 33 (19–52) | 36.9 (29–45) | 33.7 (25–46) | HA-12, PAP-8, VC-12 | 18.9 (8–37) | 5.75 (2–15) | NR | None | HA resolution in 7/12, unchanged in 5/12, PAP resolution in 5/8, unchanged in 2, unknown in 1, VC resolution in 7/12, unchanged in 5/12 | 14.2 (2–26) |
*Range and median were only data available in this paper. Since no mean value was available, these data were not included in the age analysis.
Bilat, bilateral; BMI, body mass index; CSF, cerebrospinal fluid; HA, headache; LTS, left transverse sinus; NR, not reported; PAP, papilledema; PT, pulsatile tinnitus; RTS, right transverse sinus; VC, visual changes.